%0 Journal Article
%T Reply to comment on: ˇ°Advantages of bevacizumab for aggressive posterior retinopathy of prematurityˇ±
%A Michael J. Shapiro
%A Michael P. Blair
%A Sarah Hilkert Rodriguez
%A Sidney A. Schechet
%J Archive of "Taiwan Journal of Ophthalmology".
%D 2019
%R 10.4103/tjo.tjo_10_19
%X We would like to thank Dr. Samanta for interest in our recent manuscript regarding aggressive posterior retinopathy of prematurity (APROP).[1
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557064/